Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for protection against chemotherapy-induced ovarian injury in women with malignant tumors
ChiCTR1900027489Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of metformin in ovarian injury (2 arms), sponsored by Tongji Hospital. Primary endpoint: Ovarian function recovery. Started Nov 2019; status: recruiting.
02
Drugs
metformin
03
Conditions
ovarian injury
Beyond the preview
Go deeper on ChiCTR1900027489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027489.